{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:13:48Z","timestamp":1792602828629,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1124\/mol.114.091603","type":"journal-article","created":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T05:41:38Z","timestamp":1396071698000},"page":"887-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Epirubicin Upregulates UDP Glucuronosyltransferase 2B7 Expression in Liver Cancer Cells via the p53 Pathway"],"prefix":"10.1016","volume":"85","author":[{"given":"Dong Gui","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter I.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.114.091603_bib1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1124\/dmd.108.024711","article-title":"Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin","volume":"37","author":"Bains","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.091603_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1476-4598-10-80","article-title":"Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells","volume":"10","author":"Basseville","year":"2011","journal-title":"Mol Cancer"},{"key":"10.1124\/mol.114.091603_bib3","first-page":"1","article-title":"Human UGT2B7 catalyzes morphine glucuronidation","volume":"25","author":"Coffman","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.091603_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/dmd.30.2.129","article-title":"UDP glucuronosyltransferase mRNA levels in human liver disease","volume":"30","author":"Congiu","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.091603_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12012-007-0015-3","article-title":"Role of anthracyclines in the era of targeted therapy","volume":"7","author":"Cort\u00e9s-Funes","year":"2007","journal-title":"Cardiovasc Toxicol"},{"key":"10.1124\/mol.114.091603_bib6","doi-asserted-by":"crossref","first-page":"e47696","DOI":"10.1371\/journal.pone.0047696","article-title":"Anti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cells","volume":"7","author":"Dellinger","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1124\/mol.114.091603_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"el-Deiry","year":"1993","journal-title":"Cell"},{"key":"10.1124\/mol.114.091603_bib8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/dmd.32.3.340","article-title":"Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression","volume":"32","author":"Gardner-Stephen","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.091603_bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/carcin\/bgs318","article-title":"Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53","volume":"34","author":"Goldstein","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1124\/mol.114.091603_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.fpc.0000215068.06471.35","article-title":"The caudal-related homeodomain protein Cdx2 and hepatocyte nuclear factor 1alpha cooperatively regulate the UDP-glucuronosyltransferase 2B7 gene promoter","volume":"16","author":"Gregory","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/mol.114.091603_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ctrv.2007.02.003","article-title":"The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology","volume":"33","author":"Harmsen","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1124\/mol.114.091603_bib12","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/sj.onc.1210263","article-title":"Coping with stress: multiple ways to activate p53","volume":"26","author":"Horn","year":"2007","journal-title":"Oncogene"},{"key":"10.1124\/mol.114.091603_bib13","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/mol.110.065953","article-title":"A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3\u03b1,17\u03b2-diol glucuronide","volume":"78","author":"Hu","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.114.091603_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1124\/mol.109.057380","article-title":"Estrogen receptor alpha, fos-related antigen-2, and c-Jun coordinately regulate human UDP glucuronosyltransferase 2B15 and 2B17 expression in response to 17beta-estradiol in MCF-7 cells","volume":"76","author":"Hu","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.114.091603_bib15","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1124\/dmd.110.035436","article-title":"Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells","volume":"38","author":"Hu","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.091603_bib16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/dmd.113.056630","article-title":"Polymorphisms and Haplotypes of the UDP-Glucuronosyltransferase 2B7 Gene Promoter","volume":"42","author":"Hu","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.091603_bib17","first-page":"686","article-title":"Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7","volume":"29","author":"Innocenti","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.091603_bib18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0026-895X(24)26503-2","article-title":"Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter","volume":"57","author":"Ishii","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.114.091603_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/bjc.1983.86","article-title":"Distribution of 4\u2032epi-doxorubicin in human tissues","volume":"47","author":"Italia","year":"1983","journal-title":"Br J Cancer"},{"key":"10.1124\/mol.114.091603_bib20","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1124\/dmd.109.027227","article-title":"Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers","volume":"37","author":"Izukawa","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.091603_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/00498250701744633","article-title":"Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination","volume":"38","author":"Jeong","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1124\/mol.114.091603_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev.pharmtox.47.120505.105337","article-title":"Aldo-keto reductases and bioactivation\/detoxication","volume":"47","author":"Jin","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.114.091603_bib23","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1124\/dmd.109.028225","article-title":"Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10","volume":"37","author":"Kerdpin","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.091603_bib24","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1016\/0006-2952(88)90069-X","article-title":"Different cytotoxicity and metabolism of doxorubicin, daunorubicin, epirubicin, esorubicin and idarubicin in cultured human and rat hepatocytes","volume":"37","author":"Le Bot","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.114.091603_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2144\/000113999","article-title":"LASAGNA-Search: an integrated web tool for transcription factor binding site search and visualization","volume":"54","author":"Lee","year":"2013","journal-title":"Biotechniques"},{"key":"10.1124\/mol.114.091603_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000343828","article-title":"Treatment of hepatocellular carcinoma: A systematic review","volume":"1","author":"Lin","year":"2012","journal-title":"Liver Cancer"},{"key":"10.1124\/mol.114.091603_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/mol.114.091603_bib28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1124\/dmd.104.003061","article-title":"Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element","volume":"33","author":"Lu","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.091603_bib29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","article-title":"Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily","volume":"15","author":"Mackenzie","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/mol.114.091603_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-199708000-00001","article-title":"The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence","volume":"7","author":"Mackenzie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1124\/mol.114.091603_bib31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1042\/bj20021950","article-title":"Daunorubicin-induced variations in gene transcription: commitment to proliferation arrest, senescence and apoptosis","volume":"372","author":"Mansilla","year":"2003","journal-title":"Biochem J"},{"key":"10.1124\/mol.114.091603_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","article-title":"Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies","volume":"30","author":"Marelli","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1124\/mol.114.091603_bib33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrc2730","article-title":"The expanding universe of p53 targets","volume":"9","author":"Menendez","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/mol.114.091603_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1044-579X(02)00099-8","article-title":"The p53-Mdm2 module and the ubiquitin system","volume":"13","author":"Michael","year":"2003","journal-title":"Semin Cancer Biol"},{"key":"10.1124\/mol.114.091603_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.114.091603_bib36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/FPC.0b013e32830500c9","article-title":"Genetic polymorphisms in the 5\u2032-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation","volume":"18","author":"Nakamura","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/mol.114.091603_bib37","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1124\/dmd.108.021428","article-title":"Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines","volume":"36","author":"Nakamura","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"5A","key":"10.1124\/mol.114.091603_bib38","first-page":"2893","article-title":"UGT1A10 is responsible for SN-38 glucuronidation and its expression in human lung cancers","volume":"24","author":"Oguri","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1124\/mol.114.091603_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/dmd.108.023598","article-title":"Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction","volume":"37","author":"Ohno","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.091603_bib40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00002512-199915050-00006","article-title":"Epirubicin: a review of its efficacy as adjuvant therapy and in the treatment of metastatic disease in breast cancer","volume":"15","author":"Ormrod","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1124\/mol.114.091603_bib41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/1389557511313050001","article-title":"Anthracyclines still prove effective in anticancer therapy","volume":"13","author":"Piekarski","year":"2013","journal-title":"Mini Rev Med Chem"},{"key":"10.1124\/mol.114.091603_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1389200013338379","article-title":"Human UDP-glucuronosyltransferase 2B7","volume":"2","author":"Radominska-Pandya","year":"2001","journal-title":"Curr Drug Metab"},{"key":"10.1124\/mol.114.091603_bib43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrm2395","article-title":"Transcriptional control of human p53-regulated genes","volume":"9","author":"Riley","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/mol.114.091603_bib44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/nar\/gkj460","article-title":"Regulation of the human p21(waf1\/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor","volume":"34","author":"Saram\u00e4ki","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"10, Suppl","key":"10.1124\/mol.114.091603_bib45","first-page":"2212","article-title":"Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents","volume":"53","author":"Tishler","year":"1993","journal-title":"Cancer Res"},{"key":"10.1124\/mol.114.091603_bib46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0026-895X(24)12228-6","article-title":"Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract","volume":"59","author":"Tukey","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.114.091603_bib47","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1124\/dmd.111.039727","article-title":"Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation","volume":"39","author":"Uchaipichat","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.091603_bib48","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"10.1124\/mol.114.091603_bib49","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/mol.110.070649","article-title":"Inhibition of human UGT2B7 gene expression in transgenic mice by the constitutive androstane receptor","volume":"79","author":"Yueh","year":"2011","journal-title":"Mol Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24039324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24039324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.114.091603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T17:32:25Z","timestamp":1740591145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24039324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0026895X24039324"],"URL":"https:\/\/doi.org\/10.1124\/mol.114.091603","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epirubicin Upregulates UDP Glucuronosyltransferase 2B7 Expression in Liver Cancer Cells via the p53 Pathway","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.114.091603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}